ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Oral NONTOXIC Testosterone under review by FDA
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 40159" data-attributes="member: 3"><p>This is an oral testosterone undecanoate similar to Andriol available in Canada but in a lipid matrix for better PK.</p><p></p><p>The study used 225 mg twice per day. This dose could be changed to 150 mg or 300 mg twice per day based on the target range of serum T of 300- 1100 ng/dl (average concentration). Half of patients required dose adjustment. At the end of the study, 51% had the same starting dose of 225 mg. </p><p></p><p>Here is a powerpoint presentation: <a href="http://files.shareholder.com/downloads/AMDA-2BVSIV/0x0x816504/B91020B1-7B48-45F2-BD73-1649CCFC3636/ENDO_oral_presentation_3-8-15_FINAL_v6.pdf" target="_blank">http://files.shareholder.com/downloads/AMDA-2BVSIV/0x0x816504/B91020B1-7B48-45F2-BD73-1649CCFC3636/ENDO_oral_presentation_3-8-15_FINAL_v6.pdf</a></p><p></p><p></p><p>[ATTACH]2099[/ATTACH]</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 40159, member: 3"] This is an oral testosterone undecanoate similar to Andriol available in Canada but in a lipid matrix for better PK. The study used 225 mg twice per day. This dose could be changed to 150 mg or 300 mg twice per day based on the target range of serum T of 300- 1100 ng/dl (average concentration). Half of patients required dose adjustment. At the end of the study, 51% had the same starting dose of 225 mg. Here is a powerpoint presentation: [URL]http://files.shareholder.com/downloads/AMDA-2BVSIV/0x0x816504/B91020B1-7B48-45F2-BD73-1649CCFC3636/ENDO_oral_presentation_3-8-15_FINAL_v6.pdf[/URL] [ATTACH=CONFIG]2099[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Oral NONTOXIC Testosterone under review by FDA
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top